Home > News > NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
May 9th, 2005
NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
Abstract:
NanoLogix, Inc., a Nanobiotechnology company engaged in the research, development and commercialization of technologies for the production of bacteria and disease testing kits, alternative sources of fuel, cancer therapy and remediation of toxic materials, announces that preliminary data and results of a study which confirms laboratory proof-of-concept measurements
have shown it possible to generate hydrogen in high yields via the use and adaptation of its intellectual property.
Source:
prnewswire
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||